A. Paul Mahon's most recent trade in United Therapeutics Corp was a trade of 8,300 Common Stock done at an average price of $146.0 . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 05 Feb 2026 | 8,300 | 45,081 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2026 | 8,300 | 50,100 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.92 per share. | 05 Feb 2026 | 2,748 | 38,390 (0%) | 0% | 483.9 | 1,329,824 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 481.93 per share. | 05 Feb 2026 | 2,363 | 42,241 (0%) | 0% | 481.9 | 1,138,810 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 482.57 per share. | 05 Feb 2026 | 1,103 | 41,138 (0%) | 0% | 482.6 | 532,272 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 484.92 per share. | 05 Feb 2026 | 934 | 37,456 (0%) | 0% | 484.9 | 452,911 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.52 per share. | 05 Feb 2026 | 675 | 36,781 (0%) | 0% | 485.5 | 327,725 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 480.92 per share. | 05 Feb 2026 | 477 | 44,604 (0%) | 0% | 480.9 | 229,398 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 8,300 | 58,400 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 15 Jan 2026 | 8,300 | 45,081 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 469.34 per share. | 15 Jan 2026 | 3,531 | 38,397 (0%) | 0% | 469.3 | 1,657,237 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 471.44 per share. | 15 Jan 2026 | 1,576 | 36,821 (0%) | 0% | 471.4 | 742,990 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 468.32 per share. | 15 Jan 2026 | 1,439 | 43,642 (0%) | 0% | 468.3 | 673,918 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 470.37 per share. | 15 Jan 2026 | 1,307 | 42,335 (0%) | 0% | 470.4 | 614,769 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 472.28 per share. | 15 Jan 2026 | 407 | 41,928 (0%) | 0% | 472.3 | 192,219 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 474.75 per share. | 15 Jan 2026 | 40 | 36,781 (0%) | 0% | 474.8 | 18,990 | Common Stock |
| United Therapeutics Corp | A. Mahon Paul | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 02 Jan 2026 | 8,300 | 45,081 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 8,300 | 66,700 | - | - | Stock Option | |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 487.76 per share. | 02 Jan 2026 | 2,181 | 36,981 (0%) | 0% | 487.8 | 1,063,803 | Common Stock |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.68 per share. | 02 Jan 2026 | 1,509 | 40,292 (0%) | 0% | 485.7 | 732,894 | Common Stock |
| United Therapeutics Corp | Paul Mahon A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 484.54 per share. | 02 Jan 2026 | 1,240 | 41,801 (0%) | 0% | 484.5 | 600,825 | Common Stock |
| United Therapeutics Corp | Mahon A. Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 486.85 per share. | 02 Jan 2026 | 1,130 | 39,162 (0%) | 0% | 486.8 | 550,136 | Common Stock |
| United Therapeutics Corp | A. Mahon Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 481.26 per share. | 02 Jan 2026 | 822 | 44,259 (0%) | 0% | 481.3 | 395,595 | Common Stock |
| United Therapeutics Corp | Paul Mahon A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.35 per share. | 02 Jan 2026 | 739 | 43,041 (0%) | 0% | 483.3 | 357,195 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 481.83 per share. | 02 Jan 2026 | 479 | 43,780 (0%) | 0% | 481.8 | 230,797 | Common Stock |
| United Therapeutics Corp | Mahon A. Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 489.15 per share. | 02 Jan 2026 | 200 | 36,781 (0%) | 0% | 489.2 | 97,830 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 24 Dec 2025 | 11,000 | 47,781 (0%) | 0% | 146.0 | 1,606,330 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Dec 2025 | 11,000 | 9,250 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 513.46 per share. | 24 Dec 2025 | 4,713 | 39,511 (0%) | 0% | 513.5 | 2,419,948 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 512.59 per share. | 24 Dec 2025 | 2,877 | 44,224 (0%) | 0% | 512.6 | 1,474,726 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 514.18 per share. | 24 Dec 2025 | 2,650 | 36,861 (0%) | 0% | 514.2 | 1,362,589 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 509.22 per share. | 24 Dec 2025 | 502 | 47,279 (0%) | 0% | 509.2 | 255,627 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 509.81 per share. | 24 Dec 2025 | 138 | 47,141 (0%) | 0% | 509.8 | 70,354 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 516.06 per share. | 24 Dec 2025 | 80 | 36,781 (0%) | 0% | 516.1 | 41,285 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 510.65 per share. | 24 Dec 2025 | 40 | 47,101 (0%) | 0% | 510.7 | 20,426 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 11 Dec 2025 | 11,000 | 47,781 (0%) | 0% | 146.0 | 1,606,330 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2025 | 11,000 | 20,250 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 484.31 per share. | 11 Dec 2025 | 5,220 | 41,101 (0%) | 0% | 484.3 | 2,528,076 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.22 per share. | 11 Dec 2025 | 2,804 | 38,297 (0%) | 0% | 485.2 | 1,360,550 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 486.36 per share. | 11 Dec 2025 | 1,116 | 37,181 (0%) | 0% | 486.4 | 542,777 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.25 per share. | 11 Dec 2025 | 900 | 46,321 (0%) | 0% | 483.2 | 434,923 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 482.22 per share. | 11 Dec 2025 | 560 | 47,221 (0%) | 0% | 482.2 | 270,044 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 487.36 per share. | 11 Dec 2025 | 400 | 36,781 (0%) | 0% | 487.4 | 194,946 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 26 Nov 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Nov 2025 | 11,000 | 0 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 487.21 per share. | 26 Nov 2025 | 3,350 | 38,058 (0%) | 0% | 487.2 | 1,632,145 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.15 per share. | 26 Nov 2025 | 2,210 | 43,331 (0%) | 0% | 485.2 | 1,072,182 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 486.23 per share. | 26 Nov 2025 | 1,923 | 41,408 (0%) | 0% | 486.2 | 935,020 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 484.20 per share. | 26 Nov 2025 | 1,727 | 45,541 (0%) | 0% | 484.2 | 836,207 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 488.13 per share. | 26 Nov 2025 | 1,277 | 36,781 (0%) | 0% | 488.1 | 623,344 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.05 per share. | 26 Nov 2025 | 513 | 47,268 (0%) | 0% | 483.0 | 247,803 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 13 Nov 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2025 | 11,000 | 11,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 468.48 per share. | 13 Nov 2025 | 2,070 | 36,798 (0%) | 0% | 468.5 | 969,744 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 467.37 per share. | 13 Nov 2025 | 1,992 | 38,868 (0%) | 0% | 467.4 | 930,992 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 464.19 per share. | 13 Nov 2025 | 1,979 | 42,520 (0%) | 0% | 464.2 | 918,637 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 458.16 per share. | 13 Nov 2025 | 1,063 | 46,518 (0%) | 0% | 458.2 | 487,024 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 461.36 per share. | 13 Nov 2025 | 1,040 | 45,478 (0%) | 0% | 461.4 | 479,819 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 463.32 per share. | 13 Nov 2025 | 979 | 44,499 (0%) | 0% | 463.3 | 453,590 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 466.24 per share. | 13 Nov 2025 | 884 | 40,860 (0%) | 0% | 466.2 | 412,153 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 465.36 per share. | 13 Nov 2025 | 776 | 41,744 (0%) | 0% | 465.4 | 361,123 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 456.39 per share. | 13 Nov 2025 | 200 | 47,581 (0%) | 0% | 456.4 | 91,278 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 469.12 per share. | 13 Nov 2025 | 17 | 36,781 (0%) | 0% | 469.1 | 7,975 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 30 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 11,000 | 22,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 449.46 per share. | 30 Oct 2025 | 3,441 | 42,555 (0%) | 0% | 449.5 | 1,546,606 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 450.64 per share. | 30 Oct 2025 | 2,247 | 40,308 (0%) | 0% | 450.6 | 1,012,579 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 451.57 per share. | 30 Oct 2025 | 1,849 | 38,459 (0%) | 0% | 451.6 | 834,952 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 452.33 per share. | 30 Oct 2025 | 1,285 | 37,174 (0%) | 0% | 452.3 | 581,243 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 448.56 per share. | 30 Oct 2025 | 1,143 | 45,996 (0%) | 0% | 448.6 | 512,706 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 447.34 per share. | 30 Oct 2025 | 642 | 47,139 (0%) | 0% | 447.3 | 287,195 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 454.15 per share. | 30 Oct 2025 | 393 | 36,781 (0%) | 0% | 454.1 | 178,480 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 16 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 11,000 | 33,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 431.72 per share. | 16 Oct 2025 | 2,516 | 41,310 (0%) | 0% | 431.7 | 1,086,199 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 432.59 per share. | 16 Oct 2025 | 2,078 | 39,232 (0%) | 0% | 432.6 | 898,920 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 428.51 per share. | 16 Oct 2025 | 1,908 | 45,873 (0%) | 0% | 428.5 | 817,595 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 433.45 per share. | 16 Oct 2025 | 1,652 | 37,580 (0%) | 0% | 433.5 | 716,061 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 429.61 per share. | 16 Oct 2025 | 1,092 | 44,781 (0%) | 0% | 429.6 | 469,136 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 430.59 per share. | 16 Oct 2025 | 955 | 43,826 (0%) | 0% | 430.6 | 411,212 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 434.76 per share. | 16 Oct 2025 | 798 | 36,782 (0%) | 0% | 434.8 | 346,937 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 435.00 per share. | 16 Oct 2025 | 1 | 36,781 (0%) | 0% | 435 | 435 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2025 | 11,000 | 44,000 | - | - | Stock Option | |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 02 Oct 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul Mahon A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 437.15 per share. | 02 Oct 2025 | 3,136 | 39,506 (0%) | 0% | 437.2 | 1,370,905 | Common Stock |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 438.17 per share. | 02 Oct 2025 | 1,905 | 37,601 (0%) | 0% | 438.2 | 834,710 | Common Stock |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 436.24 per share. | 02 Oct 2025 | 1,881 | 42,642 (0%) | 0% | 436.2 | 820,566 | Common Stock |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 435.22 per share. | 02 Oct 2025 | 1,828 | 44,523 (0%) | 0% | 435.2 | 795,574 | Common Stock |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 433.72 per share. | 02 Oct 2025 | 1,430 | 46,351 (0%) | 0% | 433.7 | 620,224 | Common Stock |
| United Therapeutics Corp | Mahon A. Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 440.16 per share. | 02 Oct 2025 | 474 | 36,781 (0%) | 0% | 440.2 | 208,636 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 439.19 per share. | 02 Oct 2025 | 346 | 37,255 (0%) | 0% | 439.2 | 151,959 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2025 | 11,000 | 55,000 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 18 Sep 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 406.39 per share. | 18 Sep 2025 | 3,222 | 40,086 (0%) | 0% | 406.4 | 1,309,394 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 405.45 per share. | 18 Sep 2025 | 2,973 | 43,308 (0%) | 0% | 405.5 | 1,205,403 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 407.42 per share. | 18 Sep 2025 | 2,105 | 37,981 (0%) | 0% | 407.4 | 857,613 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 408.11 per share. | 18 Sep 2025 | 1,200 | 36,781 (0%) | 0% | 408.1 | 489,737 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 404.33 per share. | 18 Sep 2025 | 1,100 | 46,281 (0%) | 0% | 404.3 | 444,760 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 402.50 per share. | 18 Sep 2025 | 400 | 47,381 (0%) | 0% | 402.5 | 161,000 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 04 Sep 2025 | 11,000 | 47,781 (0%) | 0% | 135.4 | 1,489,620 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2025 | 11,000 | 66,000 | - | - | Stock Option |